Skye Bioscience receives Nasdaq delisting notice for failing minimum stockholders' equity

Skye Bioscience, Inc.

Stockholders' equity was $9,011,804, below Nasdaq Global Market's $10M minimum requirement.
Nasdaq gave 45 days (until June 29, 2026) to submit a compliance plan; extension possible to Nov 9, 2026.
No immediate impact on trading; stock continues to trade under 'SKYE'.
Company is evaluating alternative courses of action to regain compliance; no assurance of success.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.